Adient plc (NYSE:ADNT) filed its Annual Report on Form 10-K for the fiscal year ended September 30, 2026, disclosing operational and financial information for one of the automotive industry's largest global seating suppliers.
Legato Merger Corp. IV filed its Annual Report on Form 10-K with the SEC on November 13, 2026, covering the fiscal year ended August 31, 2026, disclosing its status as a blank-check special purpose acquisition company listed on NYSE American.
Freightos Limited disclosed in an 8-K equivalent press release on November 13, 2026, that it received a written notification letter from Nasdaq on November 10, 2026, citing non-compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market.
FiEE, Inc. (NASDAQ:FIEE) released unaudited financial results for the three and nine months ended September 30, 2026, on November 13, 2026, reporting a 382.1% year-on-year revenue increase and a swing from net loss to net income for the nine-month period.
Invesco Mortgage Capital Inc. filed an 8-K on November 13, 2026, announcing a $0.12 per share cash dividend for November 2026 and disclosing preliminary, unaudited financial data as of October 31, 2026.
Montanova Capital, LLC, Averill Master Fund, Ltd., and Aaron Cowen filed Amendment No. 2 to Schedule 13G with the SEC on November 13, 2026, disclosing their beneficial ownership of Aura Biosciences, Inc. common stock as of September 30, 2026.
Karpus Management, Inc. filed Amendment No. 4 to its Schedule 13G on November 13, 2026, disclosing beneficial ownership of preferred shares in Eagle Point Institutional Income Fund as of September 30, 2026.
CNO Financial Group, Inc. filed an 8-K on November 13, 2026, announcing that its Board of Directors declared a quarterly cash dividend of $0.18 per share on the company's common shares, payable December 23, 2026.
Montanova Capital, LLC, Averill Master Fund, Ltd., and Aaron Cowen filed a Schedule 13G Amendment No. 1 with the SEC on November 13, 2026, disclosing beneficial ownership positions in Faeth Therapeutics, Inc. common stock as of September 30, 2026.
Karpus Management, Inc. filed an amended Schedule 13G on November 13, 2026 with the SEC, disclosing beneficial ownership of 1,493,275 shares of common stock in Future Money Acquisition Corp. as of September 30, 2026.